INVO Bioscience, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by INVO Bioscience, Inc. (trading symbol: INVO) on September 15, 2021. The report details the results of the Company's annual meeting of stockholders held on the same date. The registrant is incorporated in Nevada and its principal executive offices are located in Sarasota, Florida.
Key Financial Metrics
This filing is a corporate governance report regarding stockholder votes and does not contain financial performance data. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Voting Results
The meeting had a quorum with 7,834,280 shares present out of 10,464,035 shares entitled to vote. The following proposals were approved:
- Election of Directors: Seven nominees were elected to the board of directors. Jeffrey Segal and Rebecca Messina received the highest "For" votes (3,596,628 and 3,596,960 respectively), while Kevin Doody received the lowest "For" votes (2,763,909) among the nominees.
- Say-on-Pay Proposal: Stockholders approved the resolution approving named executive officer compensation with 2,322,176 votes "For" versus 148,822 "Against".
- Say When on Pay Proposal: Stockholders voted to hold future advisory votes on executive compensation every 3 years (952,447 votes), which was the plurality choice over every 2 years (921,018 votes) or 1 year (596,174 votes).
- Ratification of Auditors: The selection of M&K CPAS, PLLC as the independent registered public accounting firm for the fiscal year ending December 31, 2021, was ratified with 6,982,144 votes "For".
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors beyond the standard disclosure of the voting process. No unusual items or contingencies were reported in this document.
Key Facts for Investor Verification
- Verify the full composition of the newly elected board of directors and their tenure terms.
- Confirm the frequency of future executive compensation advisory votes is set to every 3 years.
- Note that M&K CPAS, PLLC has been ratified as the independent auditor for the 2021 fiscal year.
- Review the significant number of broker non-votes (4,202,976) which did not affect the outcome of the director elections but were recorded.